Qube Research & Technologies (QRT)
LYEL icon

Qube Research & Technologies (QRT)’s Lyell Immunopharma LYEL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.11M Buy
55,110
+46,059
+509% +$1.08M ﹤0.01% 2440
2025
Q4 		$279K Buy
+9,051
New +$203K ﹤0.01% 2970
2024
Q1 		– Sell
-425
Closed -$16.5K – 4707
2023
Q4 		$16.5K Buy
+425
New +$15.3K ﹤0.01% 3518
2022
Q1 		– Sell
-563
Closed -$87K – 2770
2021
Q4 		$87K Buy
+563
New +$126K ﹤0.01% 2165
2021
Q3 		– Sell
-2,275
Closed -$739K – 2546
2021
Q2 		$739K Buy
+2,275
New +$746K 0.01% 1075

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
GP
GSK plc London $599M AUM
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return